This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
Is ELV's Capital Allocation Strategy Creating Long-Term Value?
by Rajshree Sipani
Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.
ELVNegative Net Change UNHNegative Net Change HUMPositive Net Change
artificial-intelligence automation finance insurance medical smart-health
Can UNH's Lifestyle Spending Account Redefine Employee Benefits?
by Rajshree Sipani
UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.
UNHNegative Net Change HUMPositive Net Change ELVNegative Net Change
artificial-intelligence insurance medical smart-health
FAF Outperforms Industry, Trades Near 52-Week High: Time to Hold?
by Zacks Equity Research
First American's commercial title strength, AI adoption and rising investment income support growth, though housing weakness remains a risk.
FAFNegative Net Change RNRNegative Net Change AXSNegative Net Change NMIHNegative Net Change
insurance
AJG Stock Trading at a Discount to Industry at 2.74X: Time to Hold?
by Zacks Equity Research
Arthur J. Gallagher's organic growth, active acquisitions and capital deployment support long-term expansion despite margin and leverage challenges.
AJGNegative Net Change BRONegative Net Change ERIENegative Net Change WTWNegative Net Change
insurance
Zacks.com featured highlights include Ross Stores, Suzano, Bilbao Vizcaya Argentaria, Globe Life and AMETEK
by Zacks Equity Research
High-ROE stocks are in focus as market volatility rises, with five companies highlighted for profitability, earnings growth or consistent performance.
ROSTPositive Net Change AMENegative Net Change BBVANegative Net Change SUZPositive Net Change GLPositive Net Change
insurance
ITIC vs DGICA: Which Insurance Stock is the Better Buy?
by Debasmita Chatterjee
Investors Title's housing market tailwinds and scalable business model position it for stronger long-term growth, while Donegal Group offers stability and income. Which stock is the better buy?
DGICANegative Net Change ITICNegative Net Change
insurance
Accelerant's Growth Story Hinges on Fee-Based Momentum
by Kaibalya Pravo Dey
ARX is shifting toward a capital-light, fee-based model as AI, third-party capacity and member growth reshape its earnings story.
ARXPositive Net Change KNSLNegative Net Change RYANNegative Net Change
finance insurance
Can These 3 Insurance Trends Fuel Accelerant's Growth Story?
by Kaibalya Pravo Dey
ARX is benefiting from AI, third-party capital and fronting trends, but investors still await proof that these drivers can deliver lasting diversification.
ARXPositive Net Change RYANNegative Net Change SKWDNegative Net Change
finance insurance insurance-premium
Is Accelerant Stock a Buy After Its Sharp Pullback and Nearly 16X P/E?
by Kaibalya Pravo Dey
ARX has fallen sharply, but revenue growth, rising fee-based earnings and platform expansion keep its growth story alive despite balanced risks.
ARXPositive Net Change BRONegative Net Change RYANNegative Net Change
finance insurance
GL Outperforms Industry, Trades at a Discount: How to Play the Stock?
by Zacks Equity Research
Globe Life's premium growth, rising sales, AI initiatives and capital returns support long-term growth as underwriting discipline and investment income strengthen earnings.
GLPositive Net Change AFLNegative Net Change UNMPositive Net Change AMSFNegative Net Change
insurance